Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 807 results for "daiichi sankyo"

Real world ETNA registries of new once-daily edoxaban start in Europe
European Pharmaceutical Review

Real world ETNA registries of new once-daily edoxaban start in...

Daiichi Sankyo has announced that the first patient has been enrolled in ETNA-AF-Europe (Edoxaban Treatment in routiNe clinical prActice Atrial Fibrillation Europe). ETNA-VTE-Europe (Edoxaban Treatment in routiNe clinical prActice Venous ... European Pharmaceutical Review, 5 days ago
[x]  

Daiichi Sankyo : Revision to 'Results Briefing (Results for Q1 FY2015)'

Release date- 31072015 - Tokyo, Japan - Daiichi Sankyo Company, Limited today announced a revision as follows to the 'Results Briefing (Results for Q1 FY2015)' materials originally disclosed at 1:00pm on Thursday , July 31, 2015 . Revised item ...
 4 Traders3 weeks ago Daiichi Sankyo Q1 Profit, Revenue Up - Quick Facts  RTTNews.com4 weeks ago

Federal Circuit approves PTO's interim procedure on patent term adjustments

Digest of Daiichi Sankyo Company, LTD. v. Michelle K. Lee, Director, United States Patent and Trademark Office, No. 2014-1280 (Fed. Cir. July 2, 2015) (precedential). On appeal from D.D.C. Before Moore, Reyna , and Taranto. Procedural Posture : ...
 Lexology1 month ago

Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences.

PRWeb Continuing Education Company (CEC) and Daiichi Sankyo Inc have awarded independent educational grants in support of an interaction simulation session entitled "NOACS: What the Evidence Shows in Managing AFib, Stroke Prevention and DVT/PE." ...
 Industrial Info Financials3 weeks ago PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor  Orthopedics Today4 weeks ago
[x]  
European Pharmaceutical Review

NICE recommends edoxaban for deep vein thrombosis

UK's National Institute for Health and Care Excellence (NICE) has recommended Daiichi Sankyo's once-daily Lixiana® (edoxaban) for the treatment and prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults. The final ...
 European Pharmaceutical Review3 days ago Daiichi scores another NICE nod for Lixiana  Pharmafile2 weeks ago U.K. Agency Recommends Edoxaban for Deep Vein Thrombosis, Pulmonary Embolism  Diagnostic & Invasive Cardiology2 weeks ago NICE recommends once-daily LIXIANA for preventing stroke and systemic embolism  GM Journal3 weeks ago
Sys-Con Media

Pieris to Get 7th Milestone Payment from Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics [Professional Services Close - Up]

Pieris Pharmaceuticals recently reported it will receive its third milestone payment for the second program in its discovery and development collaboration with Daiichi Sankyo Company, Limited, and seventh milestone payment overall under the multi ...
 Pharmacy Choice1 month ago Pieris to Receive Seventh Milestone Payment From Daiichi Sankyo Collaboration to Develop Anticalin(R) Therapeutics  PharmiWeb1 month ago PIERIS PHARMACEUTICALS : to Get 7th Milestone Payment from Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics  4 Traders1 month ago Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2015  Sys-Con Media2 weeks ago
[x]  

Compliance - Hear from CCO from Lundbeck, Daiichi Sankyo and Novartis

 9ija News.com1 month ago
Trade Arabia

Top biotech industry players to meet at BioJapan

Key players from the biotech industry from more than 30 countries are set to gather at Asia's leading biotechnology partnering event in Japan in October. The 17th edition of BioJapan 2015 will run from October 14 to 16 at Pacifico Yokohama, said ...
 Trade Arabia16 hours ago Biotech Industry Key Players from 30 Countries to Gather at BioJapan 2015!  EnvironmentGuru.com1 day ago Asia's Largest Business Partnering Event - Biotech Industry Key Players from 30 Countries to Gather at BioJapan 2015!  4 Traders1 day ago Asia s Largest Business Partnering Event Biotech Industry Key Players from 30 Countries to Gather at BioJapan 2015  India Online.in1 day ago
[x]  
European Pharmaceutical Review

Combination of Roche medicines Cotellic and Zelboraf approved in Switzerland for the treatment of patients with advanced melanoma

Roche has announced that the Swiss licensing and supervisory authority for therapeutic products (Swissmedic) has approved combination therapy with Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of patients with advanced ...
 European Pharmaceutical Review2 days ago
Nikkei Asian Review

Ranbaxy a bitter pill for Sun Pharma

NEW DELHI -- India's Sun Pharmaceutical Industries is finding it harder than expected to integrate with former rival, Ranbaxy Laboratories, which it bought from Japan's Daiichi Sankyo for $4 billion in March. Close Dilip Shanghvi Reuters ...
 Nikkei Asian Review2 days ago Sun Pharma net profit falls 60% to Rs.479 crore  Livemint.com2 weeks ago After a profit warning, Sun Pharma seeks to tap global debt market to raise $1 billion  Economic Times1 month ago Sun Pharma in process to integrate Ranbaxy, overhauls combined global operations  Economic Times1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less